Suven Pharma shares off two-month high; here is how analysts view Cohance merger
Suven Pharma share price, Suven Pharma news: Suven Pharmaceuticals (SUVENPHAR) shares retreated from a two-month high touched this week after the Hyderabad-based pharma company announced the merger of contract development and manufacturing organisation (CDMO) and merchant API platform provider Cohance Lifesciences with itself. Here's how analysts view the Suven-Cohance merger.
Suven Pharma shares touched their highest level since January 12 this week after the company announced a merger with Cohance Lifesciences. | Representational image | Image credit: Reuters